Published in RSC Adv on January 09, 2012
Expression of hepatitis B surface antigen in transgenic plants. Proc Natl Acad Sci U S A (1992) 2.43
Nanoparticles for the delivery of genes and drugs to human hepatocytes. Nat Biotechnol (2003) 2.34
Dual-surface modification of the tobacco mosaic virus. J Am Chem Soc (2005) 1.86
Folic acid-mediated targeting of cowpea mosaic virus particles to tumor cells. Chem Biol (2007) 1.70
Natural supramolecular building blocks. Wild-type cowpea mosaic virus. Chem Biol (2002) 1.64
Unnatural amino acid incorporation into virus-like particles. Bioconjug Chem (2008) 1.54
Systemic trafficking of plant virus nanoparticles in mice via the oral route. Virology (2005) 1.53
Bio-distribution, toxicity and pathology of cowpea mosaic virus nanoparticles in vivo. J Control Release (2007) 1.53
Icosahedral virus particles as addressable nanoscale building blocks. Angew Chem Int Ed Engl (2002) 1.49
High efficiency transformation by electroporation of Pichia pastoris pretreated with lithium acetate and dithiothreitol. Biotechniques (2004) 1.43
Hydrazone ligation strategy to assemble multifunctional viral nanoparticles for cell imaging and tumor targeting. Nano Lett (2010) 1.42
Natural supramolecular building blocks. Cysteine-added mutants of cowpea mosaic virus. Chem Biol (2002) 1.29
Chemical modification of viruses and virus-like particles. Curr Top Microbiol Immunol (2009) 1.28
On-virus construction of polyvalent glycan ligands for cell-surface receptors. J Am Chem Soc (2008) 1.26
C terminus of infectious bursal disease virus major capsid protein VP2 is involved in definition of the T number for capsid assembly. J Virol (2001) 1.22
Structural polymorphism of the major capsid protein of a double-stranded RNA virus: an amphipathic alpha helix as a molecular switch. Structure (2005) 1.14
Protein precipitation and denaturation by dimethyl sulfoxide. Biophys Chem (2007) 1.12
A cowpea mosaic virus nanoscaffold for multiplexed antibody conjugation: application as an immunoassay tracer. Biosens Bioelectron (2005) 1.11
The 2.6-Angstrom structure of infectious bursal disease virus-derived T=1 particles reveals new stabilizing elements of the virus capsid. J Virol (2006) 1.10
Potato virus X as a novel platform for potential biomedical applications. Nano Lett (2010) 1.08
Utilisation of plant viruses in bionanotechnology. Org Biomol Chem (2007) 1.07
Chemical introduction of reactive thiols into a viral nanoscaffold: a method that avoids virus aggregation. Chembiochem (2007) 1.04
Cowpea mosaic virus for material fabrication: addressable carboxylate groups on a programmable nanoscaffold. Langmuir (2006) 1.02
Crystal structure of infectious bursal disease virus VP2 subviral particle at 2.6A resolution: implications in virion assembly and immunogenicity. J Struct Biol (2006) 1.01
Chemical modification of a viral cage for multivalent presentation. Chem Commun (Camb) (2002) 1.01
The Red clover necrotic mosaic virus capsid as a multifunctional cell targeting plant viral nanoparticle. Bioconjug Chem (2010) 0.97
Heterologous expression of the modified coat protein of Cowpea chlorotic mottle bromovirus results in the assembly of protein cages with altered architectures and function. J Gen Virol (2004) 0.96
Electrophoresis of proteins and protein-protein complexes in a native agarose gel. Anal Biochem (2000) 0.95
Stabilization of virus-like particles with poly(2-oxazoline)s. Angew Chem Int Ed Engl (2011) 0.95
Turnip yellow mosaic virus as a chemoaddressable bionanoparticle. Bioconjug Chem (2007) 0.94
Stability and assembly in vitro of bacteriophage PP7 virus-like particles. J Nanobiotechnology (2007) 0.94
Icosahedral virus particles as polyvalent carbohydrate display platforms. Chembiochem (2003) 0.93
A Viral Platform for Chemical Modification and Multivalent Display. J Nanobiotechnology (2003) 0.92
Controlled integration of polymers into viral capsids. Biomacromolecules (2009) 0.92
Virus-templated silica nanoparticles. Small (2009) 0.92
Cowpea mosaic virus capsid: a promising carrier for the development of carbohydrate based antitumor vaccines. Chemistry (2008) 0.92
Assembly of hybrid bacteriophage Qbeta virus-like particles. Biochemistry (2009) 0.91
Genetically engineered Tobacco mosaic virus as nanoparticle vaccines. Expert Rev Vaccines (2008) 0.90
Ligand exchange of major histocompatibility complex class II proteins is triggered by H-bond donor groups of small molecules. J Biol Chem (2001) 0.89
Decoration of cowpea mosaic virus with multiple, redox-active, organometallic complexes. Small (2006) 0.88
Environmentally benign synthesis of virus-templated, monodisperse, iron-platinum nanoparticles. Dalton Trans (2009) 0.83
Blue fluorescent antibodies as reporters of steric accessibility in virus conjugates. Bioconjug Chem (2003) 0.83
Infectious bursal disease subviral particles displaying the foot-and-mouth disease virus major antigenic site. Vaccine (2008) 0.83
Virus-based nanoparticles with inorganic cargo: what does the future hold? Small (2011) 0.83
Expression of a foreign epitope on infectious pancreatic necrosis virus VP2 capsid protein subviral particle (SVP) and immunogenicity in rainbow trout. Antiviral Res (2010) 0.81
Antigenicity of infectious pancreatic necrosis virus VP2 subviral particles expressed in yeast. Vaccine (2007) 0.80
Viral nanoparticles as macromolecular devices for new therapeutic and pharmaceutical approaches. Int J Physiol Pathophysiol Pharmacol (2010) 0.78
Prototype protein assembly as scaffold for time-resolved fluoroimmuno assays. J Am Chem Soc (2007) 0.78
Separation of pure and immunoreactive virus-like particles using gel filtration chromatography following immobilized metal ion affinity chromatography. Biotechnol Prog (2001) 0.78
Cloning and nucleotide analysis of the vp2 gene of a very virulent infectious bursal disease virus isolate from Iran. Acta Virol (2006) 0.78
Formation of subviral particles of the capsid protein VP2 of infectious bursal disease virus and its application in serological diagnosis. J Virol Methods (2009) 0.77
Disruption of leaves and initial extraction of wildtype CPMV virus as a basis for producing vaccines from plants. J Biotechnol (2002) 0.76
Selective flocculation and precipitation for the improvement of virus-like particle recovery from yeast homogenate. Biotechnol Prog (2000) 0.76